For over 60 years, the Cancer Research Foundation’s mission is to raise funds to fund early-career cancer scientists with the goal of contributing to transformational events in the prevention, treatment and cure for cancer.
We are “cancer research venture philanthropists,” making early investments in the ideas and minds of innovative and entrepreneurial cancer researchers.
Young Investigator Awards
The Young Investigator Awards was created to enable promising young investigators to initiate successful scientific careers.
This award provides the seed capital to nurture young scientists in the pursuit of independent hypotheses, to develop the preliminary data to compete for major grants, and to support scientific innovation in the war against cancer.
Why Cancer Research?
In 2016, 1.6 million people were diagnosed with cancer according to the *National Cancer Institute
About 595,690 Americans are expected to die of cancer each year in the United States*
Worldwide cancer cases are expected to rise 50% from 14 million to 21 million by 2030*
Your Donation Hard at Work
Funding Bold Ideas
Supporting Innovative Minds
Rising Stars with Bold New Ideas
Milan Chheda, MD, Assistant Professor of Medicine and Neurology at Washington University St. Louis received a 2016 Young Investigator Award for his work to fight Glioblastoma, one of the most deadly forms of brain cancer.
In a recent publication, Dr. Chheda, along with a team of researchers discovered a way to potentially use the zika virus to treat Glioblastoma. Your generous support has enabled the Cancer Research Foundation to support Dr. Chheda, and his continuing work in the fight against cancer.
Pioneers who Paved the Way
As early as the mid-1970’s, the CRF was funding early career cancer scientists such as Janet Rowley, MD. Using new techniques of chromosome identification, she was among the first to prove that some cancers were cause by genetic mutations. This research, carried out at the University of Chicago and supported by the CRF, led the way to proving linkages between genetics and cancer, a theory rejected by the scientific community until that time.
Rowley stated, “The most difficult time in the career of a beginning young scientist is the first few years. One has no ‘track record’ just when the need for money to hire a technician to help with experiments, to buy supplies and equipment, is the greatest.”